Neuronetics, Inc.
STIM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001227636
In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Neuronetics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 99 | 2 | 95 | −2 |
| Shares | 21.2M | 16.5K | 42.3M | +21.1M (+99.6%) |
| Value | $57.8M | $44.0K | $58.3M | +$512.7K (+0.9%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Neuronetics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Madryn Asset Management, LP | 18,475,893 | $25.5M | 73.43% |
| Lane Generational LLC | 1,705,197 | $2.35M | 2.13% |
| Renaissance Technologies LLC | 474,900 | $655.4K | 0.00% |
| JBF Capital, Inc. | 233,166 | $321.8K | 0.05% |
| Dauntless Investment Group, LLC | 160,927 | $222.1K | 0.82% |
| Aristides Capital LLC | 136,400 | $188.2K | 0.07% |
| Qube Research & Technologies Ltd | 108,208 | $149.3K | 0.00% |
| BlueCrest Capital Management Ltd | 40,000 | $55.2K | 0.00% |
| Pathstone Holdings, LLC | 32,231 | $44.5K | 0.00% |
| Abel Hall, LLC | 28,605 | $39.5K | 0.01% |
| StoneX Group Inc. | 16,917 | $23.3K | 0.00% |
| Engineers Gate Manager LP | 10,661 | $14.7K | 0.00% |
| FreeGulliver LLC | 5,000 | $6.90K | 0.00% |
| GAMMA Investing LLC | 681 | $940 | 0.00% |
| United Financial Planning Group LLC | 100 | $138 | 0.00% |
Sold out (17)
Institutions that held Neuronetics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| EHP Funds Inc. | 209,385 | $571.6K |
| Centiva Capital, LP | 117,322 | $320.3K |
| Marex Group plc | 60,200 | $164.3K |
| Axq Capital, LP | 45,284 | $123.6K |
| LPL Financial LLC | 35,100 | $95.8K |
| D. E. Shaw & Co., Inc. | 31,628 | $86.3K |
| Jump Financial, LLC | 28,000 | $76.4K |
| Omers Administration Corp | 27,000 | $73.7K |
| Atom Investors LP | 26,854 | $73.3K |
| Raymond James Financial Inc | 24,164 | $66.0K |
| Larson Financial Group LLC | 17,813 | $48.6K |
| Quadrature Capital Ltd | 14,666 | $40.2K |
| Sherbrooke Park Advisers LLC | 12,156 | $33.2K |
| Intrua Financial, LLC | 11,917 | $32.5K |
| R Squared Ltd | 11,257 | $30.7K |
| Comerica Bank | 5,000 | $13.7K |
| FNY Investment Advisers, LLC | 3,000 | $8.00K |
Not filed for Q4 2025 yet (2)
Institutions that held Neuronetics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Wolverine Trading, LLC | 16,332 | $43.4K |
| Optimum Investment Advisors | 200 | $546 |